Lexpos News

MHRA Class 2 Medicines Notification: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) Drug alert number: EL(25)A/27 Date issued: 12 June 2025 Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton. [...]

The post MHRA Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection (Maxearn Limited) appeared first on Community Pharmacy England.

A new streamlined process for making claims for the Discharge Medicines Service (DMS) will come into effect from 6th July 2025. Following feedback from Community Pharmacy England about the current lengthy claim process, NHS England and NHSBSA have agreed to introduce a shortened process for making claims for DMS. In time, an API will be [...]

The post DMS: Shortened claim journey on MYS from July 2025 appeared first on Community Pharmacy England.

Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released generic equivalent versions instead. The table below includes the Pfizer products that have recently transitioned from brand to generic along with information on ordering [...]

The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

The Government’s Spending Review has concluded, with Chancellor Rachel Reeves today announcing the Government’s new spending priorities. The announcement included a 3% real terms uplift to NHS funding, for each of the coming three years, with the Government reiterating its commitment to its three shifts for healthcare: moving care closer to home, from treatment to [...]

The post Government announces Spending Review Outcome appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...]

The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.